1. Volume 131, Issue 1, Pages 8-14 (October 2013)
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas 
Sharon E. Johnatty, Jonathan Beesley, Bo Gao, Xiaoqing Chen, Yi Lu, Matthew H. Law, Michelle J. Henderson, Amanda J. Russell, Ellen L. Hedditch, Catherine Emmanuel, Sian Fereday, Penelope M. Webb, Ellen L. Goode, Robert A. Vierkant, Brooke L. Fridley, Julie M Cunningham, Peter A. Fasching, Matthias W. Beckmann, Arif B. Ekici, Estrid Hogdall, Susanne K. Kjaer, Allan Jensen, Claus Hogdall, Robert Brown, Jim Paul, Sandrina Lambrechts, Evelyn Despierre, Ignace Vergote, Jenny Lester, Beth Y. Karlan, Florian Heitz, Andreas du Bois, Philipp Harter, Ira Schwaab, Yukie Bean, Tanja Pejovic, Douglas A. Levine, Marc T. Goodman, Michael E. Camey, Pamela J. Thompson, Galina Lurie, Joellen Shildkraut, Andrew Berchuck, Kathryn L. Terry, Daniel W. Cramer, Murray D. Norris, Michelle Haber, Stuart MacGregor, Anna deFazio, Georgia Chenevix-Trench 
Gynecologic Oncology 
Volume 131, Issue 1, Pages 8-14 (October 2013)
DOI: /j.ygyno
Copyright © 2013 The Authors Terms and Conditions

2. Fig. 1
Forest plot of study-specific estimates for rs and overall survival for patients with nil residual disease receiving any chemotherapy regimen Estimates for HAW and NCO missing due to insufficient data for this subgroup.
Gynecologic Oncology  , 8-14DOI: ( /j.ygyno )
Copyright © 2013 The Authors Terms and Conditions

3. Fig. 2
Kaplan–Meier survival analysis of ABCB1 gene expression in serous ovarian cancer. In the AOCS cohort, high expression of ABCB1 is associated with shorter PFS, either (A) in the overall cohort, or (B) in the subgroup of patients with sub-optimally debulked tumors. Kaplan–Meier curves were generated following dichotomisation of gene expression to high or low expression with respect to the optimal cut-point, determined as the 15th percentile in the whole cohort, or the 30th percentile in the sub-optimally debulked subgroup. P-values were calculated according to the log-rank test.
Gynecologic Oncology  , 8-14DOI: ( /j.ygyno )
Copyright © 2013 The Authors Terms and Conditions